Original article
Gene reprogramming in exercise-induced cardiac hypertrophy in swine: A transcriptional genomics approach

https://doi.org/10.1016/j.yjmcc.2014.10.006Get rights and content

Highlights

  • Exercise training in swine produced 16% cardiac left ventricle hypertrophy.

  • Microarray analysis identified 339 upregulated and 408 downregulated genes.

  • In promoter regions of these genes, 41 TF binding sites were overrepresented.

  • DNA-binding assays with nuclear extracts identified 23 TFs with altered activity.

  • Integrated analysis found YY1, PAX6 and GR as modulators of physiologic hypertrophy.

Abstract

Cardiac hypertrophy of the left ventricle (LV) in response to dynamic exercise-training (EX) is a beneficial adaptation to increased workload, and is thought to result from genetic reprogramming. We aimed to determine which transcription factors (TFs) are involved in this genetic reprogramming of the LV in swine induced by exercise-training. Swine underwent 3–6 weeks of dynamic EX, resulting in a 16% increase of LV weight/body weight ratio compared to sedentary animals (P = 0.03). Hemodynamic analysis showed an increased stroke volume index (stroke volume/body weight + 35%; P = 0.02). Microarray-analysis of LV tissue identified 339 upregulated and 408 downregulated genes (false discovery rate < 0.05). Of the human homologues of the differentially expressed genes, promoter regions were searched for TF consensus binding sites (TFBSs). For upregulated and downregulated genes, 17 and 24 TFBSs were overrepresented by > 1.5-fold (P < 0.01), respectively. In DNA-binding assays, using LV nuclear protein extracts and protein/DNA array, signal intensity changes > 2-fold were observed for 23 TF-specific DNA probes. Matching results in TFBS and protein/DNA array analyses were obtained for transcription factors YY1 (Yin Yang 1), PAX6 (paired box 6) and GR (glucocorticoid receptor). Notably, PAX6 and GR show lower signals in TFBS and protein/DNA array analyses upon exercise-training, whereas we previously showed higher signals for these factors in the remodeled LV of swine post-myocardial infarction (MI). In conclusion, we have identified transcription factors that may drive the genetic reprogramming underlying exercise-training induced LV hypertrophy in swine. PAX6 and GR are among the transcription factors that are oppositely regulated in LV hypertrophy after exercise-training and MI. These proteins may be at the base of the differences between pathological and physiological hypertrophy.

Introduction

Cardiac hypertrophy and remodeling is the response of the heart to an increased workload, stress or injury, in an attempt to maintain or increase cardiac output [1], [2]. Pathological hypertrophy as it occurs in hypertension, valvular diseases or after myocardial infarction (MI), is an independent risk factor for the later development of heart failure [3], [4]. In contrast, physiological hypertrophy such as that occurring during normal growth, pregnancy, or after prolonged exercise-training, is not associated with an increased risk for cardiovascular disease [5], [6]. Exercise-induced hypertrophy is not associated with increased fibrosis and apoptosis, and decreased capillary density, as is seen in various forms of pathological hypertrophy [7]. Physiological hypertrophy and pathological hypertrophy therefore have different cellular and molecular phenotypes which are thought to result from different genetic reprogramming [7], [8], [9].

The majority of studies into the molecular mechanisms underlying physiological hypertrophy have employed rodents subjected to treadmill running, voluntary wheel running or swim training. Various models of physiological hypertrophy in rodents have identified an important role for growth factors such as insulin-like growth factor (IGF-1), and phosphatidylinositol-3-kinase/Akt signaling [10]. Gene expression profiling has shown that expression of cell survival and fatty acid oxidation genes is altered after physiological hypertrophy, whereas genes involved in apoptosis and inflammation were mainly affected in pathological hypertrophy [8], [11], [12], [13]. However, there are significant differences in cardiac physiology between rodents and large laboratory animals [14], [15], such as swine, which in many aspects mimics human cardiac physiology and hemodynamics more closely than rodents [14]. Thus, similar to humans, prolonged exercise-training in swine produces cardiac hypertrophy [16], [17], increases coronary blood flow capacity [18], increases stroke volume [17], and decreases heart rate [16]. However, compared to murine models, studies in large animals into the molecular mechanisms of physiological hypertrophy, and the differences with pathological hypertrophy are scarce.

We hypothesized that LV hypertrophy results from genetic reprogramming through a limited number of transcription factors. We have previously reported on the changes in gene expression profiles, and implicated transcription factors, that underlie hypertrophy of the left ventricle (LV) during recovery from a MI [19]. Here, we studied the molecular pathways that underlie physiological hypertrophy and the TFs that drive these changes in LV hypertrophy caused by 3–6 weeks of dynamic exercise-training in swine. Using the changes in gene expression profiles, we explored the differentially expressed genes for common transcription factor binding sites (TFBSs), and combined these data with protein/DNA array analysis of protein extracts prepared from LV nuclei.

Section snippets

Experimental animals

Studies were performed in accordance with the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996) and with approval of the Erasmus University Medical Center Animal Care Committee. Cardiac tissue was collected from 2 to 3 months old pre-pubescent female and neutered male Yorkshire × Landrace swine.

Swine underwent a 3–6 week long (average 31 days, range 18–42 days) incremental dynamic exercise protocol (EX, n = 11). Swine ran 5 days/week on a treadmill starting at 3 

Anatomical and hemodynamical data

In swine that were exercise-trained for 3–6 weeks physiological hypertrophy was observed. A 16% increase (P = 0.03) in LV weight to body weight ratio was observed compared with sedentary animals (SED), indicative of LV hypertrophy (Fig. 1A). This was accompanied by a trend towards a lower basal heart rate (− 12%; P = 0.083; Table 1). Cardiac dimensions, as determined by echocardiography in subsets of animals, tended to be higher in EX than SED animals, but this did not reach statistical significance (

Discussion

The present study is the first to investigate the changes in cardiac gene expression during physiological hypertrophy of the left ventricle in a large animal model in an unbiased and integrative fashion. In the present study a protocol of 3–6 weeks of EX in pre-pubescent female and neutered male pigs resulted in a 16% increase in LV weight to body weight ratio and a 35% increase in stroke volume index, whereas heart rate showed a trend towards lower values. To identify TFs that potentially drive

Conclusions

By using an unbiased approach, we identified changes in gene expression and the TFs that are likely involved in the genetic reprogramming that underlies physiological LV hypertrophy in a large animal model. By comparing these genes to previously published gene expression and TF activity data on pathological hypertrophy, a number of genes and TFs were identified that are differentially regulated in both forms of hypertrophy, e.g. PAX6 and GR. These proteins might be at the base of the

Disclosures

None.

Acknowledgments

This work was supported by a grant of the Netherlands Heart Foundation (NHS2005B234).

References (42)

  • D. Levy et al.

    Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

    N Engl J Med

    (May 31 1990)
  • H.D. White et al.

    Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction

    Circulation

    (Jul 1987)
  • S. Gielen et al.

    Exercise training in coronary artery disease and coronary vasomotion

    Circulation

    (Jan 2 2001)
  • B.J. Maron et al.

    The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death

    Circulation

    (Oct 10 2006)
  • V. Beisvag et al.

    Pathological and physiological hypertrophies are regulated by distinct gene programs

    Eur J Cardiovasc Prev Rehabil

    (Dec 2009)
  • N. Frey et al.

    Cardiac hypertrophy: the good, the bad, and the ugly

    Annu Rev Physiol

    (2003)
  • J.R. McMullen et al.

    Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy

    Proc Natl Acad Sci U S A

    (Oct 14 2003)
  • C.L. Galindo et al.

    Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure

    BMC Physiol

    (2009)
  • S.W. Kong et al.

    Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats

    Physiol Genomics

    (Mar 21 2005)
  • C.C. Strom et al.

    Expression profiling reveals differences in metabolic gene expression between exercise-induced cardiac effects and maladaptive cardiac hypertrophy

    FEBS J

    (Jun 2005)
  • J.A. Dixon et al.

    Large animal models of heart failure: a critical link in the translation of basic science to clinical practice

    Circ Heart Fail

    (May 2009)
  • Cited by (11)

    • Paired box 6 inhibits cardiac fibroblast differentiation

      2020, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      Consequently, CF differentiation is an important target for preventing cardiac fibrosis; however, the molecular mechanisms underlying CF differentiation have not yet been fully elucidated. A previous study suggested that the DNA-binding activity of the transcription factor paired box 6 (Pax6) is oppositely regulated in models of exercise-induced hypertrophy and post-myocardial infarction-induced hypertrophy [4]. Thus, Pax6 may play a role in the pathological process of hypertrophy and may participate in the regulation of CF differentiation during cardiac fibrosis.

    • Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction

      2019, Journal of Molecular and Cellular Cardiology
      Citation Excerpt :

      There is evidence that Yy1 overexpression is strongly linked with the pathophysiology of adverse cardiac remodeling. In 2014, Kuster and co-workers reported an increase in Yy1 in the remodeled LV of swine post-MI [12]. Using an experimental heart failure model and human heart failure samples, Sucharov and co-workers showed that Yy1 is upregulated in the damaged tissue and acts as a negative regulator of αMyHC gene expression, leading to cardiac hypertrophy [13].

    • Corticosteroid Receptors in Cardiac Health and Disease

      2022, Advances in Experimental Medicine and Biology
    View all citing articles on Scopus
    1

    Present address: Department of Physiology, VU University Medical Center, Amsterdam, The Netherlands.

    View full text